Article
Predicting therapeutic responses in head and neck squamous cell carcinoma from TP53 mutation and The mutation of TP53 could be detected by cfDNA
2023-03-08
Abstract excerpt
<h4>Objectives: </h4> Head and neck squamous cell carcinoma (HNSCC) was increasing globally. The mutation of the TP53 was the most common of all somatic genomic changes in HNSCC, and TP53 mutation was associated with the response of immunotherapeutic and chemotherapeutic. Tumor-derived circulating cell-free DNA (cfDNA) was minimally invasive method to determine genetic alterations for cancer. The study aimed to ex...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0f746c04-6e09-5ac3-acd1-8ed1910b0317
- DOI
- 10.21203/rs.3.rs-2552100/v1
